Clinical trials
HPV clinical trials
Below are recruiting hpv clinical trials, each written for real people, not researchers. We’re tracking 257 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07225530Recruiting
Screening and treatment for cervical cancer in women with HIV
This trial tests a program to screen and treat HIV-positive women for cervical cancer in La Romana, Dominican Republic. It may help catch and manage cervical cancer early.
La RomanaAges 25 years+ - NCT07246590RecruitingPhase 3
Cantharidin treatment for common warts in children and adults
This trial tests a medication called cantharidin for treating common warts. It is for people age 2 and older who are generally healthy and have at least one common wart on the body (but not on palms, soles, face, or genitals). Participants cannot use other wart treatments during the study.
Saint Augustine, FloridaAges 2 years+ - NCT04131413RecruitingPhase 1
HPV vaccine given through the skin for HPV16 cervical disease
This early-phase study tests a vaccine designed to help your immune system fight HPV16, a type of human papillomavirus linked to abnormal cells in the cervix. You may or may not be living with HIV, and the team will check safety and immune response after giving the vaccine in a specific way.
Birmingham, AlabamaAges 19 years+ - NCT07290621RecruitingPhase 2
Toripalimab with standard treatment for HPV-positive throat cancer
This study tests adding a new immunotherapy drug (toripalimab) to standard chemo for HPV-positive throat cancer. It aims to see if this combination works better than chemo alone for patients whose cancer has spread to nodes but not to other parts of the body.
Chicago, IllinoisAges 18 years+ - NCT06210854RecruitingPhase 2
HPV16/18 Vaccine Trial for Cervical Lesions
This trial tests a new vaccine (pBI-11) given with a device that uses mild electric pulses to help the vaccine enter cells. It is for people who have HPV16 or 18 but no high-grade cervical changes.
Birmingham, AlabamaAges 18 years+ - NCT07678047Enrolling by invitation
Improving Cervical Cancer Screening in Ethiopia
This study tests a virtual peer-mentoring program (Project ECHO) to help healthcare providers in Ethiopia improve cervical cancer screening for women living with HIV. It aims to see if this training approach increases screening rates and connects patients to care.
Addis AbabaAges 18 years+ - NCT07358910Recruiting
Tracking infectious diseases in communities
This study looks at how infections spread in villages in Cambodia. If you live in a participating village, you might help us understand and prevent disease outbreaks.
Phnom Penh, Phnom PenhAges 2–75 - NCT01011712Recruiting
Study immune causes of severe viral infections
This study looks at why some people have severe or unusual viral infections, even when they do not have a known immune problem. It collects blood and tissue samples to better understand possible inherited immune issues and may help future diagnosis and treatment.
Bethesda, MarylandAges 2–100 - NCT07454915RecruitingPhase 2
PVX4 vaccine for HPV16-related cervical dysplasia
This trial tests a new vaccine called PVX4 for women with HPV16-related cervical dysplasia. It aims to see if the vaccine can help clear the high-risk HPV infection and the abnormal cells on the cervix.
The Bronx, New YorkAges 18–60 - NCT07457918RecruitingPhase 3
Long-term safety of cantharidin gel for common warts
This study follows people who completed an earlier cantharidin trial to see how safe and effective the medicine is over a longer time. You may join if you still have treatable warts or finished the earlier study.
Saint Augustine, FloridaAges 2 years+ - NCT07480902Recruiting
Comparing two tests for cervical cancer detection
This trial compares a liquid-based cytology test with a molecular screening test to find early changes in the cervix that could lead to cancer. It may help you understand which test is better at detecting these changes before they become serious.
Mexico City, Mexico CityAges 18–85 - NCT07512921Recruiting
Gene Expression Study for HPV-Negative Head and Neck Cancer
This study compares gene patterns in tumor tissue and blood samples from patients with HPV-negative head and neck cancer. Understanding these patterns may help doctors better understand the disease and develop better treatments.
MilanAges 18 years+ - NCT07412743Enrolling by invitation
HPV vaccine program for teens in school health centers
This trial tests a program at school health centers to help teens get their HPV vaccine and learn about wellness. If you're due for the HPV shot, this could be a helpful way to get it in a familiar place.
Portland, OregonAges 9–18 - NCT06943547Enrolling by invitation
Study to improve cervical cancer screening in Puerto Rico
This trial tests how well certain programs can increase cervical cancer screening among women in Puerto Rico. If you are overdue for a Pap or HPV test, this study may help you get screened.
San Juan, PRAges 25–65 - NCT05528237Enrolling by invitation
HPV self-test to help cervical cancer screening access
This trial studies whether letting people collect their own HPV test sample (a private, at-home option) makes cervical cancer screening easier for people with HIV and/or those who are often underserved. If you’ve declined a Pap test or it’s been 6+ months since your last screening, this may offer a more convenient way to check for HPV and cervical cancer risk.
Seattle, WashingtonAges 25 years+ - NCT05524480Enrolling by invitation
Help Latina women get overdue breast, cervical care
This trial tests an implementation program that helps clinics better provide breast and cervical cancer screening and HPV vaccination to Latina women who are behind on recommended care. It may help you catch up on screening or start HPV vaccination and connect you to low-cost services.
Houston, TexasAges 18–74 - NCT04755517Enrolling by invitation
Cervical screening for women unprotected by HPV herd effect
This study checks how well cervical screening works for certain unvaccinated women depending on whether they are protected by “herd effect” from HPV vaccination in the community. It may help improve screening plans for women who may be at higher risk.
HämeenlinnaAges 25–25
Hear when a new HPV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hpv?
- Yes. Clin2 currently lists 257 recruiting hpv studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hpv trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hpv trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.